Personalized treatment selection in colorectal cancer with peritoneal metastasis: Do we need statistically validated indicators or cultural shift?

doi:10.4251/wjgo.v17.i4.104110

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (35)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=34

Apr 15, 2025 (publication date) through Mar 25, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastrointest Oncol. Apr 15, 2025; 17(4): 104110
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.104110

Personalized treatment selection in colorectal cancer with peritoneal metastasis: Do we need statistically validated indicators or cultural shift?

Fabrizio D'Acapito, Massimo Framarini, Daniela Di Pietrantonio, Giorgio Ercolani

Fabrizio D'Acapito, Massimo Framarini, Daniela Di Pietrantonio, Giorgio Ercolani, General and Oncologic Surgery, Morgagni-Pierantoni Hospital, AUSL Romagna, Forli 47121, Emilia-Romagna, Italy

Giorgio Ercolani, Department of Medical and Surgical Sciences, University of Bologna, Bologna 40126, Emilia-Romagna, Italy

Author contributions: D’Acapito F wrote the original draft; D'Acapito F and Framarini M contributed to conceptualization, writing, reviewing and editing; Di Pietrantonio D and Ercolani G participated in drafting the manuscript; and all authors have read and approved the final version of the manuscript.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Fabrizio D'Acapito, General and Oncologic Surgery, Morgagni-Pierantoni Hospital, AUSL Romagna, Via Carlo Forlanini 34, Forli 47121, Emilia-Romagna, Italy. fabrizioda@gmail.com

Received: December 10, 2024
Revised: January 3, 2025
Accepted: January 8, 2025
Published online: April 15, 2025
Processing time: 105 Days and 22.2 Hours

Core Tip

Core Tip: In this study, Wu conducted a single-center retrospective analysis on patients with colorectal cancer and peritoneal metastasis. Findings indicate that a high neutrophil-to-lymphocyte ratio and low hemoglobin levels are independent risk factors for poor prognosis in this population. The developed nomogram accurately predicted overall survival for this patient group, demonstrating its potential as a valuable prognostic tool for this population. Over-simplification of the selection pathway may deny access to curative treatments to patients who could benefit.